MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    The study of clonidine growth hormone study amongst definite MSA, PD, PSP, and PAF patients to assess its feasibility as a future non-invasive biomarker

    S. Bhattacharjee, E. Vichayanrat, L. Watson, V. Iodice (London, United Kingdom)

    Objective: To analyze the sensitivity and specificity of the clonidine growth hormone (CGH) to distinguish probable multiple system atrophy (MSA) from pure autonomic failure (PAF),…
  • 2022 International Congress

    All that emerge is not Lupus

    M. Spitz, S. de Souza, I. Sodré, B. Panichelli (Rio de Janeiro, Brazil)

    Objective: The aim of this article is to report a rare case of Huntington's disease (HD) in a patient with chorea and previous diagnosis of…
  • 2022 International Congress

    IkT-148009 as a potential disease-modifying therapy in PD

    M. Werner, S. Karuppagounder, R. Rush, T. Kelly, T. Dawson, V. Dawson (Atlanta, USA)

    Objective: Modeling Parkinson’s disease in mice suggests c-Abl activation is required for PD initiation and progression, and therefore inhibition of c-Abl could be a strategy…
  • 2022 International Congress

    Sexual dysfunctions in Parkinson’s disease and their influence on partnership – data from the PRISM study

    T. Kinateder, D. Marinho, L. Hatzler, D. Gruber, G. Ebersbach, F. Gandor (Beelitz-Heilstaetten, Germany)

    Objective: To assess the demographics of sexual dysfunction in the PRISM cohort and analyze their influence on patients’ quality of life and their partnership. Background:…
  • 2022 International Congress

    Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia

    A. Silbergleit, L. Schultz, K. Isabell, J. Turnbull, E. Boettcher, R. Konnai, C. Sidiropoulos, N. Patel (West Bloomfield, USA)

    Objective: 1.To determine if Botulinum toxin (BoNT) injection improves oropharyngeal swallowing in individuals with cervical dystonia (CD) as determined by objective data from videofluorographic swallowing studies…
  • 2022 International Congress

    A Literature Review: Effectiveness of Transcranial Direct Current Stimulation on gait speed and freezing of gait in patients with Parkinson’s disease

    T. Mok (hong kong, Hong Kong)

    Objective: The objective of this review is to update evidence on benefits of tDCS on gait speed and freezing of gait (FOG) for PD patients…
  • 2022 International Congress

    Learning to PERSEVERE: Efficacy and Feasibility of Peer Mentor Support and Caregiver Education in Lewy Body Dementia

    J. Fleisher, F. Akram, S. Hess, M. Levin, D. Dodson, G. Stebbins, M. Tosin, B. Ouyang, J. Chodosh (Chicago, USA)

    Objective: To examine the effects of peer mentoring on caregiving mastery, Lewy Body Dementia (LBD) knowledge, and dementia attitudes among LBD family caregivers. Background: Few…
  • 2022 International Congress

    DBS Experience In A Pediatric Neurowilson Case

    S. Bozkaya Yilmaz, N. Olgaç Dündar, G. Basarir, P. Gencpinar, A. Ersen (Izmir, Turkey)

    Objective: I have chosen this case to demonstrate an atypical presentation of Neuro-Wilson disease without a prominent hepatic involvement. I have also aimed to call…
  • 2022 International Congress

    Hemichorea-hemiballismus syndrome without damage to the subthalamic nucleus?

    A. Aguiar, I. Duarte, J. Jucá Neto, G. Do Nascimento, J. Dos Santos (Fortaleza, Brazil)

    Objective: Discuss a case of Non-ketotic hyperglycemia hemiballismus hemichorea that preserves the subthalamic nucleus (STN). Background: Non-ketotic hyperglycemia hemiballismus hemichorea is a pathology characterized by…
  • 2022 International Congress

    PD-MCI is frequent in candidates to subthalamic deep brain stimulation and is associated with structural brain alterations

    K. Dujardin, Q. Devignes, S. Daoudi, R. Viard, R. Lopes, N. Betrouni, G. Kuchcinski, AS. Rolland, JC. Corvol, D. Devos (Lille, France)

    Objective: To determine the prevalence of mild cognitive impairment (PD-MCI) in Parkinson's disease (PD) patients, candidates to subthalamic deep brain stimulation (STN-DBS) as well as the frequency…
  • « Previous Page
  • 1
  • …
  • 497
  • 498
  • 499
  • 500
  • 501
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley